Edition:
United Kingdom

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

0.64USD
20 Apr 2018
Change (% chg)

$-0.00 (-0.70%)
Prev Close
$0.64
Open
$0.65
Day's High
$0.65
Day's Low
$0.61
Volume
60,833
Avg. Vol
43,220
52-wk High
$6.44
52-wk Low
$0.61

Latest Key Developments (Source: Significant Developments)

SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Reshape Lifesciences Inc ::SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING.  Full Article

Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​.  Full Article

Reshape Lifesciences qtrly loss per share $1.06‍​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Reshape Lifesciences Inc ::Reshape Lifesciences announces third quarter 2017 financial results.Q3 revenue $360,000.Reshape Lifesciences Inc - qtrly loss per share $1.06‍​.  Full Article

CVI Investments Inc reports 9.9 pct passive stake in Enteromedics Inc
Friday, 26 Aug 2016 

: CVI Investments Inc reports 9.9 pct passive stake in enteromedics inc, as of August 18, 2016 - Sec Filing Source - http://bit.ly/2cetnP4 Further company coverage: [ETRM.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Enteromedics Q2 loss per share $0.49
Thursday, 4 Aug 2016 

Enteromedics Inc : Enteromedics reports second quarter 2016 financial results . Q2 loss per share $0.49 .Q2 sales $276,000.  Full Article

EnteroMedics says CFP Greg Lea to retire effective as of October 1, 2016
Wednesday, 6 Jul 2016 

Enteromedics Inc :On june 30, greg lea, co's cfo said intends to retire and leave his position with company effective as of october 1, 2016 - sec filing.  Full Article

BRIEF-Reshape Lifesciences Announces Approval Of Reshape Balloon In Saudi Arabia

* RESHAPE LIFESCIENCES CONTINUES EXPANSION IN MIDDLE EAST WITH APPROVAL OF RESHAPE BALLOON IN SAUDI ARABIA